Trials
Search / Trial NCT00000390

Antidepressant Treatment of AIDS Related Depression.

Launched by GEIGY PHARMACEUTICALS · Jan 17, 2000

Apply for Trial

Trial Information

Current as of January 15, 2025

Completed

Keywords

Adult Acquired Immunodeficiency Syndrome Depression Female Human Imipramine Male Middle Age Acquired Immunodeficiency Syndrome *Complications Depression *Drug Therapy Depression Etiology Imipramine *Therapeutic Use

ClinConnect Summary

To test the effectiveness treating AIDS related depression with imipramine hydrochloride.

Depression syndromes are commonly associated with chronic, disabling, and fatal diseases. Due to the relentless course of HIV infection, there is a certain reluctance to treat the associated depression. In other illness, it has been proven that treating the depression often results in improvement of overall health status.

This is a placebo controlled trial. Half of the patients are given imipramine hydrochloride every day for 6 weeks. Assessment is done by self reports and the Hamilton Depression Rat...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Patient must be ambulatory and relatively good health. Even if unable to work at least able to partially care care for self and not demented.
  • • May have been alcoholic or drug abuser 6 months previous.
  • • Unspecified
  • • CD4 Unspecified.
  • Exclusion Criteria:
  • • Non ambulatory patients or those requiring extensive help in self care are excluded.
  • • Non ambulatory patients or those requiring extensive help in self care are excluded.
  • • Current alcohol or drug abuse.
  • • Unspecified

Trial Officials

Frances A

Study Chair

Manning D

Study Chair

About Geigy Pharmaceuticals

Geigy Pharmaceuticals, a renowned leader in the pharmaceutical industry, is dedicated to advancing healthcare through innovative research and development. With a rich history of delivering high-quality therapeutic solutions, Geigy focuses on a diverse range of medical areas, including oncology, cardiology, and neurology. Committed to the principles of scientific excellence and patient safety, the company employs cutting-edge technologies and rigorous clinical trial methodologies to bring new treatments to market. Geigy Pharmaceuticals remains steadfast in its mission to improve patient outcomes and enhance the quality of life for individuals worldwide.

Locations

New York, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials